ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
CpG Island Annotation and Regulatory Element Mapping Tool
A specialized SaaS tool that annotates CpG islands, predicts transcriptional impact, and maps regulatory elements using integrated multi-omics datasets and functional genomics data. Generates revenue through tiered subscription models and premium API access for biotech and pharma research teams.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Clinical Methylation Profiling and Prognosis Platform
A diagnostic-grade commercial platform converting methylation signatures into actionable clinical predictions for cancer staging, treatment response, and patient stratification. Monetizes through laboratory testing services, institutional partnerships, and integration fees with hospital information systems.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Longitudinal Methylation Tracking and Disease Monitoring Service
A commercial service platform enabling longitudinal tracking of methylation changes over time for disease progression monitoring and therapeutic response assessment. Delivers recurring revenue through patient monitoring subscriptions and personalized tracking reports for precision medicine programs.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Methylome Quality Assessment and Standardization Suite
A comprehensive quality control and standardization tool ensuring methylation data consistency across platforms, batches, and labs with automated artifact detection and correction. Generates revenue through per-project licensing, certification services, and integration with existing bioinformatics pipelines.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Tissue-Specific Methylation Reference Database and Query API
A commercial reference database containing extensively characterized tissue-specific methylation patterns with a queryable API for comparative analysis and contextual interpretation. Monetizes through subscription tiers, API usage fees, and data licensing for commercial research applications.
DNA Methylation Analysis Service Platform Dev Click to view more details →
Epigenetic Drug Target Identification and Validation Platform
A specialized platform using methylation profiling to identify and validate epigenetic drug targets and predict therapeutic efficacy for pharmaceutical development programs. Generates revenue through target validation contracts, research collaborations, and licensing of proprietary methylation-based screening assays.
DNA Methylation Analysis Service Platform Dev Click to view more details →
High-Throughput Histone PTM Screening Platform
A cloud-based SaaS platform that automates the detection and quantification of histone post-translational modifications across thousands of compounds simultaneously using mass spectrometry integration. This enables pharmaceutical companies to accelerate drug candidate selection and reduce preclinical development timelines by 40-60%.
Histone Modification Drug Discovery Platforms Click to view more details →
AI-Powered Epigenetic Drug Target Discovery Engine
An artificial intelligence platform that predicts novel histone modification patterns associated with disease states and identifies optimal drug targets through machine learning on multi-omics datasets. This delivers a scalable licensing model generating recurring revenue while reducing target validation costs for biotech partners.
Histone Modification Drug Discovery Platforms Click to view more details →
Chromatin Immunoprecipitation ChIP-seq Analysis Suite
A comprehensive software toolkit that streamlines ChIP-seq data processing, normalization, and visualization for histone modification mapping with integrated quality control and peak calling algorithms. This product monetizes through enterprise licensing and per-analysis fees, capturing significant margins from genomics research institutions and pharmaceutical R&D departments.
Histone Modification Drug Discovery Platforms Click to view more details →
Histone Acetyltransferase Inhibitor Screening Toolkit
A specialized assay development platform offering high-throughput screening libraries and protocols optimized for discovering HAT inhibitors with superior selectivity and cellular penetrance. This generates revenue through reagent sales, assay licensing fees, and tiered subscription models for ongoing platform access.
Histone Modification Drug Discovery Platforms Click to view more details →
HDAC Inhibitor Potency and Selectivity Validation Service
A contract research service providing comprehensive profiling of HDAC inhibitor candidates across all 11 human deacetylase isoforms using proprietary cell-based and biochemical assays. This creates recurring B2B revenue streams through milestone-based contracts and preferred vendor relationships with major pharmaceutical development teams.
Histone Modification Drug Discovery Platforms Click to view more details →
Multi-Omics Integration Platform for Epigenetic Biomarker Discovery
An integrated data analytics platform that correlates histone modification signatures with transcriptomics, proteomics, and phenotypic outcomes to identify predictive biomarkers for patient stratification. This enables personalized medicine applications and generates licensing revenue through pharmaceutical collaborations and clinical trial support services.
Histone Modification Drug Discovery Platforms Click to view more details →